Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

Mizuho Securities analyst Siti Panigrahi has maintained their neutral stance on PTC stock, giving a Hold rating on October 31. Siti Panigrahi ...

Analyst Jeffrey Hung of Morgan Stanley maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), retaining the price target ...

Hyperion Munitions produces an innovative enhancement for the AR-15’s mil-spec trigger design that allows for custom tuning ...

PTC Therapeutics (PTCT) reported $196.79 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.1%. EPS of -$1.39 for the same period compares to -$1.76 a ...

PTC 18 was officially designated on Sunday and while there's still a lot of uncertainty it will be a storm we'll need to watch over the week. As of Monday morning there was no center of circulation ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

For the quarter, PTC anticipates revenues to be between $598 million and $648 million. Non-GAAP earnings per share (EPS) are expected to be between $1.30 and $1.66. The Zacks Consensus Estimate ...

US-headquartered PTC, a global software company, is looking to raise its average annual investment of $70 million in India to ...

DREO, the No.1 fan & heater brand in the U.S., proudly unveils the MC706-a powerful 2-in-1 Tower Fan & Heater that brings ...